Jack W. Singer

2016

In 2016, Jack W. Singer earned a total compensation of $557.8K as Executive Vice President, Chief Scientific Officer, Interim Chief Medical Officer and Global Head of Translational Medicine at CTI BioPharma, a 83% decrease compared to previous year.

Compensation breakdown

Bonus$90,000
Option Awards$34,800
Salary$400,000
Other$32,994
Total$557,794

Singer received $400K in salary, accounting for 72% of the total pay in 2016.

Singer also received $90K in bonus, $34.8K in option awards and $33K in other compensation.

Rankings

In 2016, Jack W. Singer's compensation ranked 10,797th out of 14,075 executives tracked by ExecPay. In other words, Singer earned more than 23.3% of executives.

ClassificationRankingPercentile
All
10,797
out of 14,075
23rd
Division
Manufacturing
4,191
out of 5,486
24th
Major group
Chemicals And Allied Products
1,492
out of 1,900
22nd
Industry group
Drugs
1,199
out of 1,543
22nd
Industry
Pharmaceutical Preparations
935
out of 1,173
20th
Source: SEC filing on March 28, 2017.

Singer's colleagues

We found five more compensation records of executives who worked with Jack W. Singer at CTI BioPharma in 2016.

2016

James Bianco

CTI BioPharma

Chief Executive Officer

2016

Bruce Seeley

CTI BioPharma

Secretary

2016

Matthew Plunkett

CTI BioPharma

Executive Vice President, Chief Business Officer

2016

Richard Love

CTI BioPharma

Chief Executive Officer

2016

Louis Bianco

CTI BioPharma

Former Executive Vice President, Finance and Administration

News

You may also like